D&D Pharmatech Raises $154m To Progress MASH, Core Assets

Global Investors Provide 30% Of New Funding

 
• By Jung Won Shin
  
financing
Expects To Confirm Positive Phase II MASH Results By End-May (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business